• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Therapeutically Attenuating Neutrophil Recruitment With a CXCR2 Antagonist in Combination With Oseltamivir Ameliorates Influenza-Induced Lung Injury a

tetano

Editor, Senior Moderator
Open Forum Infect Dis. 2019 Mar 7;6(4):ofz106. doi: 10.1093/ofid/ofz106. eCollection 2019 Apr.
[h=1]Therapeutically Attenuating Neutrophil Recruitment With a CXCR2 Antagonist in Combination With Oseltamivir Ameliorates Influenza-Induced Lung Injury and Disease.[/h] Washburn ML[SUP]1[/SUP], Crosby R[SUP]2[/SUP], Remlinger K[SUP]2[/SUP], Wang F[SUP]1[/SUP], Creech D[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Mice were infected with influenza and treated with a CXCR2 antagonist in combination with antiviral or antiviral alone starting 4 days postinfection. Neutrophil recruitment to the lung was reduced, and improvements in health outcomes and lung consolidation were observed in combination-treated mice with no evidence of worsening outcome.


[h=4]KEYWORDS:[/h] CXCR2 antagonist; biomarker; influenza; neutrophils

PMID: 31041337 PMCID: PMC6483135 DOI: 10.1093/ofid/ofz106
 
Back
Top Bottom